Former Big Pharma R&D Exec Shares Thoughts On Outsourcing
By Ed Miseta, Chief Editor, Clinical Leader
Jim Hauske is president and founder of Sensor Pharmaceuticals, a company focused on the nexus of inflammation and metabolic disease. A virtual company, Sensor has established business relationships with AMRI, Absorption Systems, MPI, RenaSci, Ricerca and SciLucent. Hauske took time out from his managerial duties to share his perceptions on working with CROs. Hauske answers questions such as:
What are the benefits to outsourcing?
What metrics do you use to determine if you should outsource?
What is the biggest negative perception CROs should work to overcome?
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.